| 0.93 | 0.004 | 0.93 | Cyclophilin D inhibitor | | |
| 0.785 | 0.004 | 0.785 | Hypoglycemic | | |
| 0.709 | 0 | 0.709 | Sodium/glucose cotransporter inhibitor | | |
| 0.613 | 0 | 0.613 | Sodium/glucose cotransporter 2 inhibitor | | |
| 0.626 | 0.017 | 0.626 | Antiobesity | | |
| 0.462 | 0.005 | 0.462 | NOS3 expression enhancer | | |
| 0.469 | 0.049 | 0.469 | Transcription factor NF kappa B inhibitor | | |
| 0.399 | 0.004 | 0.399 | AMP-activated protein kinase stimulant | | |
| 0.437 | 0.061 | 0.437 | Antibacterial | | |
| 0.391 | 0.036 | 0.391 | Antioxidant | | |
| 0.42 | 0.068 | 0.42 | Calcium channel L-type activator | | |
| 0.431 | 0.093 | 0.431 | Caspase 9 stimulant | | |
| 0.378 | 0.045 | 0.378 | Apoptosis antagonist | | |
| 0.394 | 0.065 | 0.394 | Immunosuppressant | | |
| 0.357 | 0.034 | 0.357 | Hypolipemic | | |
| 0.352 | 0.038 | 0.352 | Antiamyloidogenic | | |
| 0.355 | 0.043 | 0.355 | Hypoxia-inducible factor 1 alpha inhibitor | | |
| 0.367 | 0.058 | 0.367 | Cholesterol antagonist | | |
| 0.339 | 0.042 | 0.339 | Free radical scavenger | | |
| 0.341 | 0.05 | 0.341 | Interleukin 2 agonist | | |
| 0.308 | 0.027 | 0.308 | Hepatoprotectant | | |
| 0.286 | 0.006 | 0.286 | Beta amyloid protein antagonist | | |
| 0.337 | 0.062 | 0.337 | Vasodilator, coronary | | |
| 0.393 | 0.118 | 0.393 | Alpha-glucosidase inhibitor | | |
| 0.293 | 0.019 | 0.293 | Amylase inhibitor | | |
| 0.408 | 0.135 | 0.408 | Antiinflammatory | | |
| 0.275 | 0.007 | 0.275 | Selectin antagonist | | |
| 0.331 | 0.072 | 0.331 | Antithrombotic | | |
| 0.271 | 0.025 | 0.271 | Interferon gamma antagonist | | |
| 0.291 | 0.053 | 0.291 | Angiogenesis stimulant | | |
| 0.277 | 0.041 | 0.277 | Platelet adhesion inhibitor | | |
| 0.262 | 0.059 | 0.262 | DNA synthesis inhibitor | | |
| 0.218 | 0.016 | 0.218 | UDP-glucose 4-epimerase inhibitor | | |
| 0.337 | 0.147 | 0.337 | Apoptosis agonist | | |
| 0.236 | 0.056 | 0.236 | Nitric oxide antagonist | | |
| 0.213 | 0.036 | 0.213 | Melanin inhibitor | | |
| 0.19 | 0.017 | 0.19 | Potassium channel (Ca-activated) activator | | |
| 0.203 | 0.033 | 0.203 | Monophenol monooxygenase inhibitor | | |
| 0.246 | 0.077 | 0.246 | Tumour necrosis factor alpha release inhibitor | | |
| 0.187 | 0.021 | 0.187 | MAP3K9 inhibitor | | |
| 0.199 | 0.047 | 0.199 | Protein-tyrosine phosphatase inhibitor | | |
| 0.17 | 0.018 | 0.17 | Uric acid excretion stimulant | | |
| 0.181 | 0.034 | 0.181 | Protein-tyrosine phosphatase 1B inhibitor | | |
| 0.218 | 0.076 | 0.218 | RNA-directed DNA polymerase inhibitor | | |
| 0.272 | 0.14 | 0.272 | Histamine release inhibitor | | |
| 0.182 | 0.053 | 0.182 | Interleukin 6 antagonist | | |
| 0.126 | 0.009 | 0.126 | Phosphorylase inhibitor | | |
| 0.145 | 0.036 | 0.145 | DNA repair enzyme inhibitor | | |
| 0.127 | 0.019 | 0.127 | Alpha 2d adrenoreceptor antagonist | | |
| 0.167 | 0.064 | 0.167 | Cytidine deaminase inhibitor | | |
| 0.099 | 0.005 | 0.099 | Estradiol 17 beta-dehydrogenase 2 inhibitor | | |
| 0.227 | 0.135 | 0.227 | Immunomodulator | | |
| 0.132 | 0.043 | 0.132 | Expectorant | | |
| 0.156 | 0.068 | 0.156 | Insulin secretagoues | | |
| 0.141 | 0.054 | 0.141 | DNA polymerase I inhibitor | | |
| 0.146 | 0.068 | 0.146 | Mannose-6-phosphate isomerase inhibitor | | |
| 0.095 | 0.017 | 0.095 | Antimetabolite | | |
| 0.131 | 0.059 | 0.131 | Papain-like protease (SARS coronavirus) inhibitor | | |
| 0.194 | 0.124 | 0.194 | Immunostimulant | | |
| 0.118 | 0.048 | 0.118 | Xanthine oxidase inhibitor | | |
| 0.094 | 0.027 | 0.094 | Potassium channel large-conductance Ca-activated activator | | |
| 0.121 | 0.054 | 0.121 | Estrogen antagonist | | |
| 0.106 | 0.042 | 0.106 | Triose-phosphate isomerase inhibitor | | |
| 0.113 | 0.051 | 0.113 | Toll-Like receptor 4 antagonist | | |
| 0.231 | 0.17 | 0.231 | Calcium channel activator | | |
| 0.089 | 0.031 | 0.089 | HIV-1 integrase inhibitor | | |
| 0.182 | 0.124 | 0.182 | Nitric-oxide synthase stimulant | | |
| 0.099 | 0.045 | 0.099 | NADH dehydrogenase inhibitor | | |
| 0.177 | 0.133 | 0.177 | Peptidyltransferase inhibitor | | |
| 0.112 | 0.072 | 0.112 | Cell adhesion inhibitor | | |
| 0.136 | 0.096 | 0.136 | Hexokinase inhibitor | | |
| 0.063 | 0.026 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | | |
| 0.05 | 0.013 | 0.05 | Antibiotic Aminoglycoside-like | | |
| 0.15 | 0.115 | 0.15 | Non-steroidal antiinflammatory agent | | |
| 0.093 | 0.058 | 0.093 | Thioredoxin inhibitor | | |
| 0.088 | 0.053 | 0.088 | Transcription factor NF kappa B stimulant | | |
| 0.159 | 0.125 | 0.159 | Neurotrophic factor enhancer | | |
| 0.062 | 0.029 | 0.062 | Glucosylceramidase inhibitor | | |
| 0.081 | 0.049 | 0.081 | Carbonic anhydrase XIII inhibitor | | |
| 0.108 | 0.077 | 0.108 | Microtubule formation inhibitor | | |
| 0.114 | 0.084 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.13 | 0.101 | 0.13 | Adenylate cyclase stimulant | | |
| 0.184 | 0.158 | 0.184 | Lipoxygenase inhibitor | | |
| 0.097 | 0.071 | 0.097 | Estrogen receptor beta antagonist | | |
| 0.057 | 0.031 | 0.057 | Alpha-mannosidase inhibitor | | |
| 0.108 | 0.085 | 0.108 | Aldehyde dehydrogenase inhibitor | | |
| 0.14 | 0.119 | 0.14 | ATPase inhibitor | | |
| 0.041 | 0.02 | 0.041 | Glucose-6-phosphate dehydrogenase inhibitor | | |
| 0.076 | 0.059 | 0.076 | Cell adhesion molecule inhibitor | | |
| 0.028 | 0.013 | 0.028 | Prostaglandin EP2 agonist | | |
| 0.028 | 0.013 | 0.028 | Adenosine A1 receptor agonist | | |
| 0.092 | 0.077 | 0.092 | Topoisomerase I inhibitor | | |
| 0.078 | 0.067 | 0.078 | Thioredoxin reductase inhibitor | | |
| 0.095 | 0.085 | 0.095 | Mucolytic | | |
| 0.058 | 0.049 | 0.058 | Transcription factor AP-1 inhibitor | | |
| 0.046 | 0.038 | 0.046 | Estrogen agonist | | |
| 0.022 | 0.017 | 0.022 | Dopamine D1 agonist | | |
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | | |
| 0.07 | 0.065 | 0.07 | Antineoplastic antibiotic | | |
| 0.081 | 0.077 | 0.081 | Alcohol dehydrogenase inhibitor | | |
| 0.041 | 0.038 | 0.041 | Mannosidase inhibitor | | |
| 0.081 | 0.079 | 0.081 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | | |
| 0.093 | 0.091 | 0.093 | Adenylate cyclase inhibitor | | |
| 0.025 | 0.022 | 0.025 | Uridine phosphorylase inhibitor | | |
| 0.113 | 0.111 | 0.113 | Cell wall synthesis inhibitor | | |
| 0.032 | 0.029 | 0.032 | HMG CoA reductase inhibitor | | |
| 0.112 | 0.109 | 0.112 | Cyclooxygenase inhibitor | | |
| 0.16 | 0.158 | 0.16 | DNA damaging | | |